Finance

Beta
Lists
AKTX:NASDAQ
Akari Therapeutics PLC
$10.73
+12.71%
(+1.21) 1D
$9.32
-13.14% (-1.41)
After hours
Closed: Jun 26, 4:00:02 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for AKTX...
Open
$9.37
High
$10.74
Low
$9.26
Mkt. cap
8.63M
Avg. vol.
1.58M
Volume
92.84K
52-wk high
$49.60
52-wk low
$3.02
EPS
-$414.40
Beta
1.33
Shares outstanding
1.14M
No. of employees
5
Open
$9.37
High
$10.74
Low
$9.26
Mkt. cap
8.63M
Avg. vol.
1.58M
Volume
92.84K
52-wk high
$49.60
52-wk low
$3.02
EPS
-$414.40
Beta
1.33
Shares outstanding
1.14M
No. of employees
5
News stories
From sources across the web
About Akari Therapeutics PLC
CEO-
Employees5
Founded2004
HeadquartersTampa, Florida, United States
SectorBiotechnology
Websiteakaritx.com
Analyst ratings
Based on 2 analysts giving stock ratings to AKTX in the past 3 months
Buy
Buy
1
Hold
1
Sell
0
12-month forecast
Based on 2 Wall Street analysts offering 12 month price targets for AKTX in the last 3 months.
Highest
Current $10.73
$27.00 (+151.63%)
Average
$27.00 (+151.63%)
Lowest
$27.00 (+151.63%)
Analyst
Recommendation
Action
Price target
Projected
Date
Sean Lee CFA
H.C. Wainwright
Buy
Reiterated
$27.00
+151.6%
04/21/2026
Jason McCarthy
Maxim Group
Hold
Downgraded
-
-
04/08/2026
Aydin Huseynov
Ladenburg Thalmann & Co.
Buy
Initiated
$40.00
+272.8%
01/05/2026
James Molloy
Alliance Global Partners
Buy
Reiterated
$7.00
-34.8%
11/19/2025
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
667.00K
249.00K
1.09M
1.46M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.45M
1.98M
2.14M
2.17M
Operating expense
3.12M
2.22M
3.23M
3.63M
Total operating expenses
3.12M
2.22M
3.23M
3.63M
Operating income
-3.12M
-2.22M
-3.23M
-3.63M
Other non operating income
134.00K
253.00K
3.20M
274.00K
EBT including unusual items
-1.90M
-7.49M
-5.21M
-15.31M
EBT excluding unusual items
-3.08M
-2.12M
-998.00K
-3.35M
Income tax expense
-
-1.09M
85.00K
-859.00K
Effective tax rate
-
14.53%
-1.63%
5.61%
Other operating expenses
-
-
-
-
Net income
-1.90M
-6.40M
-5.30M
-14.46M
Net profit margin
-
-
-
-
Earnings per share
-3.92
-1.06
-
-
Interest and investment income
-
1.00K
-
-
Interest expense
-50.00K
-121.00K
-723.00K
-61.00K
Net interest expenses
-50.00K
-120.00K
-723.00K
-61.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-3.12M
-2.22M
-3.22M
-
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
Give me an overview of AKTX
Explore what’s possible
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer